127 related articles for article (PubMed ID: 8263157)
1. Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves' disease.
Hidaka Y; Amino N; Iwatani Y; Itoh E; Matsunaga M; Tamaki H
J Clin Endocrinol Metab; 1993 Dec; 77(6):1667-70. PubMed ID: 8263157
[TBL] [Abstract][Full Text] [Related]
2. Onset of Graves' thyrotoxicosis after an attack of allergic rhinitis.
Hidaka Y; Masai T; Sumizaki H; Takeoka K; Tada H; Amino N
Thyroid; 1996 Aug; 6(4):349-51. PubMed ID: 8875759
[TBL] [Abstract][Full Text] [Related]
3. Increase in serum levels of autoantibodies after attack of seasonal allergic rhinitis in patients with Graves' disease.
Takeoka K; Hidaka Y; Hanada H; Nomura T; Tanaka S; Takano T; Amino N
Int Arch Allergy Immunol; 2003 Nov; 132(3):268-76. PubMed ID: 14646389
[TBL] [Abstract][Full Text] [Related]
4. Increased serum concentration of eosinophil-derived neurotoxin in patients with Graves' disease.
Hidaka Y; Kimura M; Izumi Y; Takano T; Tatsumi KI; Amino N
Thyroid; 2003 Feb; 13(2):129-32. PubMed ID: 12699586
[TBL] [Abstract][Full Text] [Related]
5. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
[TBL] [Abstract][Full Text] [Related]
6. Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients.
Tamai H; Hayaki I; Kawai K; Komaki G; Matsubayashi S; Kuma K; Kumagai LF; Nagataki S
J Clin Endocrinol Metab; 1995 May; 80(5):1481-4. PubMed ID: 7744989
[TBL] [Abstract][Full Text] [Related]
7. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
Izumi Y; Hidaka Y; Tada H; Takano T; Kashiwai T; Tatsumi KI; Ichihara K; Amino N
Clin Endocrinol (Oxf); 2002 Jul; 57(1):51-8. PubMed ID: 12100069
[TBL] [Abstract][Full Text] [Related]
8. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
9. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease.
Amino N; Tanizawa O; Mori H; Iwatani Y; Yamada T; Kurachi K; Kumahara Y; Miyai K
J Clin Endocrinol Metab; 1982 Jul; 55(1):108-12. PubMed ID: 6896207
[TBL] [Abstract][Full Text] [Related]
10. Association of seasonal allergic rhinitis is high in Graves' disease and low in painless thyroiditis.
Amino N; Hidaka Y; Takano T; Izumi Y; Tatsumi KI; Nakata Y
Thyroid; 2003 Aug; 13(8):811-4. PubMed ID: 14558923
[TBL] [Abstract][Full Text] [Related]
11. [Effects of methimazole on the evolution of the allergic rhinitis of patients with Graves' disease].
Valencia Zavala MP; Cortinas López L; Sánchez Olivas JA; Sánchez Olivas MA; Montes Montes J; Duarte Díaz RJ; León Oviedo C
Rev Alerg Mex; 2007; 54(3):71-6. PubMed ID: 17849791
[TBL] [Abstract][Full Text] [Related]
12. The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.
Burch HB; Solomon BL; Cooper DS; Ferguson P; Walpert N; Howard R
J Clin Endocrinol Metab; 2001 Jul; 86(7):3016-21. PubMed ID: 11443161
[TBL] [Abstract][Full Text] [Related]
13. [Laboratory diagnosis before onset and prediction of Graves' disease].
Hidaka Y; Tada H; Amino N
Rinsho Byori; 1997 Sep; 45(9):825-30. PubMed ID: 9311254
[TBL] [Abstract][Full Text] [Related]
14. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
15. Improved prediction of relapse of Graves' thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies.
Schott M; Eckstein A; Willenberg HS; Nguyen TB; Morgenthaler NG; Scherbaum WA
Horm Metab Res; 2007 Jan; 39(1):56-61. PubMed ID: 17226115
[TBL] [Abstract][Full Text] [Related]
16. [Long-term follow up after antithyroid drug treatment in Graves' disease].
Wille T; Müller B; Noth D; Bürgi U; Diem P
Praxis (Bern 1994); 2006 Jul; 95(29-30):1121-7. PubMed ID: 16916174
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of circulating thyroid-stimulating activities in pregnant women with Graves' disease: differential measurement of activities induced by TSH receptor antibody and hCG].
Kaneda T; Tamaki H; Hidaka Y; Amino N; Mitsuda N; Tanizawa O; Miyai K
Rinsho Byori; 1992 Sep; 40(9):941-7. PubMed ID: 1434029
[TBL] [Abstract][Full Text] [Related]
18. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease.
Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K
J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751
[TBL] [Abstract][Full Text] [Related]
19. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
McIver B; Rae P; Beckett G; Wilkinson E; Gold A; Toft A
N Engl J Med; 1996 Jan; 334(4):220-4. PubMed ID: 8531998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]